| 1 |
How might using gold nanoparticles in electrochemical sensors enhance early-stage disease detection?
|
2. By increasing surface interactions for more accurate biomarker capture |
|
Gold nanoparticles have a large surface area and excellent biocompatibility, which allow more biomolecules (bioreceptors) to be immobilized on the sensor surface. This increases the probability of binding target biomarkers, resulting in enhanced sensitivity and accuracy for early disease detection |
of gold nanoparticles improves biomolecule immobilization density.
Signal amplification: Gold nanoparticles facilitate electron transfer and amplify the electrochemical signal.
Reference: Biosensors and Bioelectronics literature highlights the role of gold nanoparticles in increasing sensor sensitivity and selectivity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following best explains how label-free electrochemical sensors support point-of-care medical diagnostics?
|
3. They provide direct measurement of target molecules with minimal preparation |
|
Label-free electrochemical sensors detect target analytes directly through changes in electrical signals without needing additional labeling agents (e.g., fluorescent or radioactive tags). This results in faster, simpler, and more cost-effective diagnostics, ideal for point-of-care settings. |
Label-free detection: Avoids the complexity and time consumption of labeling steps, facilitating rapid analysis.
Electrochemical transduction: Measures direct interactions between bioreceptors and targets, translating binding events into electrical signals.
Reference: Studies in Analytical Chemistry and Biosensors and Bioelectronics emphasize label-free sensors’ advantages for real-time, on-site diagnostics.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is electrochemical transduction considered advantageous over optical transduction in medical diagnostic sensors?
|
2. It is more compatible with smartphone integration for remote analysis |
|
Electrochemical sensors generate electrical signals that can be easily measured and processed by portable electronic devices, including smartphones. This compatibility facilitates remote, real-time monitoring and data sharing, which is essential for modern point-of-care diagnostics. Optical sensors often require bulky, expensive equipment or complex optics, limiting portability |
Electrochemical signals are easier to digitize and transmit compared to optical signals.
This advantage is emphasized in studies of portable biosensors (Biosensors and Bioelectronics, Analytical Chemistry).
Smartphone integration supports telemedicine and decentralized healthcare delivery.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which action would most effectively increase specificity in a sensor designed to detect a single disease biomarker?
|
3. Functionalizing the electrode with disease-specific aptamers |
|
Aptamers are short, single-stranded DNA or RNA molecules that bind specifically and strongly to their target molecules. Functionalizing electrodes with aptamers tailored for a specific biomarker greatly enhances selectivity and specificity by minimizing binding to unrelated molecules. |
Surface modification using aptamers or antibodies is a common strategy to improve sensor specificity.
Aptamers offer high affinity, chemical stability, and easy synthesis (Trends in Analytical Chemistry, Biosensors and Bioelectronics).
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
In a scenario where a sensor must detect ultra-low concentrations of a cancer biomarker, which modification is most critical?
|
3. Incorporating nanostructures to increase surface-to-volume ratio |
|
Nanostructures provide a high surface area relative to their volume, increasing the number of available binding sites for biomarkers. This improves signal strength and sensitivity, enabling detection of very low analyte concentrations. |
Nanomaterials like gold nanoparticles, carbon nanotubes, and graphene enhance electron transfer and amplify signals (Biosensors and Bioelectronics).
High surface-to-volume ratio is key in trace detection.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why might two electrochemical sensors using the same nanomaterial produce inconsistent results?
|
3. Variations in nanomaterial synthesis affect structural uniformity |
|
Different batches of nanomaterials can have variations in size, shape, surface chemistry, and purity, which affect their electrochemical behavior. This leads to inconsistent sensor performance and reproducibility challenges |
Synthesis reproducibility is a known challenge in nanotechnology-based sensors (ACS Nano, Sensors and Actuators B).
Standardization protocols are needed to ensure uniformity. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which characteristic makes nanotechnology-based electrochemical sensors especially suitable for wearable medical devices?
|
3. They allow miniaturization without losing sensitivity |
|
Nanotechnology enables sensors to be made very small and lightweight, which is essential for wearable devices. Despite their small size, nanomaterials provide a high surface area and excellent electron transfer properties, ensuring the sensor remains highly sensitive and accurate. |
Miniaturization is a key advantage of nanomaterials in biosensors (Biosensors and Bioelectronics, Nano Today).
This facilitates continuous, non-invasive health monitoring via wearables. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What would likely happen if the bioreceptor layer is poorly immobilized on the sensor surface?
|
3. Target biomolecules may not bind effectively, leading to weak or inaccurate signals |
|
If the bioreceptor layer is not firmly attached, it cannot efficiently capture target molecules, reducing the binding events and causing weak or unreliable sensor signals. |
Stable bioreceptor immobilization is critical for sensor specificity and sensitivity (Analytical Chemistry, Biosensors and Bioelectronics).
Poor immobilization causes signal loss and inconsistent readings.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which modification would most directly enhance electron transfer in the sensor system?
|
2. Incorporating carbon nanotubes on the electrode surface |
|
Carbon nanotubes (CNTs) are excellent conductors and increase the electrode’s surface area, promoting faster and more efficient electron transfer, which enhances sensor performance. |
CNTs are widely used to improve electrochemical sensors’ electron transfer rates (Electroanalysis, Sensors and Actuators B). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
How can digital sensing technologies best support personalized cancer care?
|
2. By collecting real-time data on patient-specific symptoms and responses |
|
Real-time monitoring captures the dynamic nature of each patient’s condition, enabling tailored treatment adjustments based on ongoing symptom changes and treatment responses. |
Personalized medicine relies on continuous, patient-specific data (Nature Reviews Clinical Oncology, Journal of Medical Internet Research). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
If a clinician needs to monitor fatigue and motion in cancer patients at home, which device should be prioritized?
|
2. Smart accelerometers in wearables |
|
Accelerometers track physical activity and movement, which are indicators of fatigue and functional status. Wearables provide convenient, continuous home monitoring |
Accelerometers are standard in activity monitoring and remote patient management (Supportive Care in Cancer, JMIR mHealth). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why is combining sensor data with patient-reported outcomes (PROs) important in digital cancer care?
|
3. It allows a holistic understanding of patient experience |
|
Sensor data provide objective physiological measurements, while PROs offer subjective insights into symptoms and quality of life. Together, they give a complete picture of patient health |
Integration of objective and subjective data enhances clinical decision-making (BMC Cancer, Journal of Clinical Oncology). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
A hospital invested in wearable digital monitoring but received low engagement from patients. Which of the following is most likely a contributing factor?
|
3. Low digital health literacy among patients |
|
Even with advanced wearable devices, if patients lack the skills or understanding to use digital health tools effectively, engagement will be low. Digital literacy is a well-known barrier in healthcare technology adoption. |
Health literacy impacts patient adoption of digital tools (JMIR, Health Informatics Journal).
User training and simplified interfaces can improve engagement. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which future trend is most aligned with the development of emerging digital cancer platforms?
|
2. Creation of pocket-sized biosensing tools integrated with smartphones |
|
Emerging trends emphasize miniaturization and smartphone integration for accessible, point-of-care cancer diagnostics, enabling real-time monitoring. |
Advances in microfluidics and biosensors support portable devices (Nature Biomedical Engineering).
Smartphone-based diagnostics increase reach and convenience.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How can real-time symptom monitoring positively affect treatment decisions?
|
3. By enabling rapid intervention before major deterioration |
|
Real-time symptom monitoring allows clinicians to detect worsening conditions early and adjust treatment promptly, improving outcomes. |
Timely interventions reduce hospitalizations and complications (Supportive Care in Cancer).
Digital health enhances dynamic care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which technology is best suited to detect rare cancer biomarkers with high precision?
|
1. Digital ELISA |
|
Digital ELISA (Enzyme-Linked Immunosorbent Assay) offers ultra-sensitive detection of rare biomarkers at very low concentrations, ideal for cancer diagnostics. |
Digital ELISA surpasses traditional ELISA sensitivity (Analytical Chemistry).
It enables precise quantification of low-abundance molecules.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
Why is collaboration between data scientists and clinicians essential in digital oncology platforms?
|
3. Data insights require clinical validation for real-world use |
|
Data scientists analyze complex datasets, but clinicians must validate and interpret these insights to ensure clinical relevance and safe patient care. |
Collaboration is essential in translating AI and data analytics into practice (Journal of Clinical Oncology, Nature Medicine).
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
Which outcome is most likely when cancer patients actively use digital health tools to track their condition?
|
2. They engage more actively in shared treatment decisions |
|
Digital tools improve patient awareness and understanding, encouraging collaboration with healthcare providers in treatment planning. |
Patient engagement correlates with better outcomes (BMC Cancer, Patient Education and Counseling).
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
A research team is developing a highly selective electrochemical sensor for detecting cancer biomarkers in blood. Based on the diagram, which combination of nanoparticle properties would most likely enhance both specificity and signal sensitivity?
|
2. Small spherical particles with antibody-conjugated targeting ligands |
|
Small size increases surface area and mobility; antibodies provide high specificity to target biomarkers, improving both selectivity and sensitivity. |
Functionalization with targeting ligands enhances binding (Biosensors and Bioelectronics).
Particle shape and surface chemistry influence performance |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
A hospital is planning to adopt a single digital sensing platform to support a wide range of diagnostic applications. Based on the image, which of the following most justifies this decision?
|
2. One platform can be customized to detect toxins, cancer biomarkers, and heavy metals using interchangeable biorecognition elements |
|
Modular platforms use interchangeable bioreceptors, making a single device adaptable for multiple diagnostic targets, increasing efficiency and cost-effectiveness. |
Modular biosensors allow multiplexed detection (Analytical Chemistry, Nature Biotechnology).
Customization enhances diagnostic versatility |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|